Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalk.

导出 LinkOut

翻译打印收藏纠错

作者： Mai O,Kadry ^[1] ; Gamal Eldein Fathy,Abd-Ellatef ^[1] ; Naglaa M,Ammar ^[1] ; Heba A,Hassan ^[1] ; Noha S,Hussein ^[1] ; Nahla N,Kamel ^[1] ; Maha M,Soltan ^[2] ; Rehab M,Abdel-Megeed ^[1] ; Abdel-Hamid Z,Abdel-Hamid ^[1]

作者单位： National Research Center, Therapeutic Chemistry Department, Al Bohouth Street, Egypt. ^[1] National Research Center, Biology Unit, Central Laboratory for Pharmaceutical and drug industries Research Institute, Chemistry of Medicinal Plants Department, Al Bohouth Street, Dokki, Egypt. ^[2]

关键词 ABCA1 Breast cancer EGFR Metabolomics PTEN

DOI 10.1016/j.toxrep.2024.101884

PMID 39886047

发布时间 2025-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Toxicology reports

2025年14卷

101884页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalk.

Toxicology reports

相似文献

Toxicology reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalk.

Toxicology reports

相似文献

Toxicology reports

相关期刊

检索历史清除